Delivery Order SPE2DR25D1100-SPE2DR26FCZ5C
- Not listed
- The Defense Logistics Agency awarded a $2,033.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 13, 2026, for supply of Nemluvio 30 mg pens, with completion targeted for February 4, 2026. This is a non-set-aside, competitively awarded contract with performance taking place at the company's headquarters in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded a $6,099.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Nemluvio 30 mg pens, with an ultimate completion date of January 30, 2026. This contract was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $5,603.16 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens. This competitively awarded contract, with no set-aside designation, was issued on November 17, 2025, and carries an ultimate completion date of December 9, 2025. The pharmaceutical products will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, under firm fixed pricing terms. This delivery order is issued against...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens with a ceiling value of $2,033.08. This contract, with an award date of December 18, 2025 and ultimate completion date of January 12, 2026, is a firm fixed-price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $4,066.16 to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens on December 2, 2025, with an ultimate completion date of December 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a $2,033.08 delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens, with an ultimate completion date of December 24, 2025. This competitive, non-set-aside contract utilizes firm fixed-price pricing and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single procurement action under AmerisourceBergen's existing relationship with the federal government's medical...
- The Defense Logistics Agency awarded a $4,066.16 delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens on January 5, 2026, with a completion date of January 27, 2026. This firm fixed-price, non-set-aside contract was issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a $7,471 delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for supply of Nemluvio 30 mg pens. The contract is a firm fixed-price, competitive award with no set-aside designation and is scheduled for completion by November 28, 2025. AmerisourceBergen will perform this order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $2,033.08 to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens on January 5, 2026, with completion scheduled for January 27, 2026. This firm fixed-price delivery order represents a non-competitive award under the contractor's existing indefinite delivery contract vehicle with DLA. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Nemluvio 30 mg pens valued at $1,929.20. This firm fixed-price delivery order was competitively awarded without set-aside on October 14, 2025, with an ultimate completion date of November 4, 2025. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCZ5CDelivery Order
This delivery order, valued at $6,099.24, awards Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) a firm fixed-price contract for Nemluvio 30 mg pens to be delivered to Conshohocken, Pennsylvania. The contract was awarded on January 13, 2026, with an ultimate completion date of February 4, 2026. This is a competitively awarded contract with no set-aside designation, funded by the Defense Logistics Agency under its Medical Supply Chain operations. This delivery order represents a task order against Amerisourcebergen's larger $999.99 billion Indefinite Delivery Contract with DLA Troop Support Medical (contract designation SPE2DX), which runs through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide, including critical medications, vaccines, medical devices, and specialty pharmaceuticals across multiple therapeutic domains. Amerisourcebergen's extensive federal contract portfolio and established relationship with the Defense Logistics Agency demonstrate its significant role as a primary pharmaceutical distributor for Department of Defense healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.1k | 1/12/26 |